Showing 141 - 160 results of 1,770 for search '(( 1 means decrease ) OR ( 10 ((nn decrease) OR (((mean decrease) OR (a decrease)))) ))*', query time: 0.19s Refine Results
  1. 141
  2. 142
  3. 143
  4. 144
  5. 145
  6. 146
  7. 147
  8. 148
  9. 149
  10. 150

    Allergenicity of roasted peanuts treated with a non-human digestive protease by Yu, Jianmei

    Published 2015
    “…The in vitro IgE-binding capacity of treated peanut extracts was determined by a competitive inhibition ELISA using pooled plasma of 10 peanut allergic patients. …”
    Get full text
    Get full text
    Get full text
  11. 151
  12. 152
  13. 153
  14. 154
  15. 155

    Implementing and Analyzing a Recursive Technique for Building Path Oblivious RAM by Rachid, Maan Haj

    Published 2018
    “…Oblivious RAM (ORAM) schemes exist in order to protect the access pattern of data in a data-store. Under an ORAM algorithm, a client accesses a data store in such a way that does not reveal which item it is interested in. …”
    Get full text
    Get full text
  16. 156
  17. 157
  18. 158

    Socket Shield Technique to Improve the Outcomes of Immediate Implant: A Systematic Review and Meta-Analysis by Scarano, Antonio

    Published 2023
    “…Meta-analyses revealed that the immediate implants placed with SST had a statistically significant decrease in horizontal (MD = −0.28, 95% CI [−0.37, −0.19], p < 0.0001), vertical (MD = −0.85, 95% CI [−1.12, −0.58], p < 0.0001), and crestal (MD = −0.35, 95% CI [−0.56, −0.13], p = 0.002) bone loss, as well as probing depth (MD = −0.64, 95% CI [−0.99, −0.29], p = 0.0003). …”
    Get full text
    Get full text
  19. 159
  20. 160

    Assessment of Dapagliflozin Effectiveness as Add-on Therapy for the Treatment of Type 2 Diabetes Mellitus in a Qatari Population by Al AdAwi R.M.

    Published 2019
    “…The main outcome measures were the differences in HbA1c and FBG from baseline at different months. Eighty-one Qatari patients were found to have received dapagliflozin during the study period; 72% of them (n = 58) were males, with a mean age of 57.0 ± 9.0 years and a mean baseline HbA1c of 9.0 ± 1.4%. …”
    Get full text
    Get full text